Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company’s pipeline includes MITOLINE, an algorithm used to perform multiple seq... Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company’s pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.02 | 0.400801603206 | 4.99 | 5.8424 | 4.02 | 15909 | 5.11622255 | CS |
| 4 | 0.27 | 5.69620253165 | 4.74 | 6.75 | 4.02 | 39942 | 5.02838057 | CS |
| 12 | 4.258 | 566.223404255 | 0.752 | 6.75 | 0.5532 | 35438 | 3.95743877 | CS |
| 26 | 1.95 | 63.7254901961 | 3.06 | 6.75 | 0.5532 | 449678 | 1.80421289 | CS |
| 52 | 4.735 | 1721.81818182 | 0.275 | 7 | 0.135 | 737994 | 1.2938129 | CS |
| 156 | 3.46 | 223.225806452 | 1.55 | 7 | 0.135 | 4922094 | 1.00723951 | CS |
| 260 | 3.46 | 223.225806452 | 1.55 | 7 | 0.135 | 4922094 | 1.00723951 | CS |
tw0122
5月前
The Truth Hurts
5月前
The Truth Hurts
5月前
makinezmoney
8月前
tw0122
9月前
tw0122
9月前
tw0122
9月前
tw0122
9月前
9Coastal
12月前
9Coastal
12月前
9Coastal
1年前
JusDePomme
1年前
longrichard
1年前
JusDePomme
1年前
LandPro
1年前
marcis
1年前
marcis
1年前
JusDePomme
1年前
LandPro
1年前
LandPro
1年前
weedtrader420
1年前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。